Key Details
Price
$16.50Annual Revenue
$274.42 MAnnual EPS
$1.23Annual ROE
18.10%Beta
1.01Events Calendar
Next earnings date:
Feb 20, 2025Recent quarterly earnings:
Nov 04, 2024Recent annual earnings:
Feb 20, 2024Next ex-dividend date:
N/ARecent ex-dividend date:
N/ANext split:
N/ARecent split:
N/AAnalyst ratings
Recent major analysts updates
Market Data
Dividend
Profitability
Efficiency
Valuation
Liquidity
Cash Flow
Institutional Ownership
Tactile Systems' top line reflects strong demand for its existing products. Workflow enhancements are driving efficiency.
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
MINNEAPOLIS, Nov. 19, 2024 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. (“Tactile Medical”; the “Company”) (Nasdaq: TCMD), a medical technology company providing therapies for people with chronic disorders, today announced that management will participate in the Piper Sandler 36th Annual Healthcare Conference, which is being held at the Lotte New York Palace in New York, NY from December 3rd – 5th. Management will participate in a fireside chat on Tuesday, December 3rd at 10:00 a.m. Central Time.
Tactile Systems Technology (TCMD) is a Zacks Rank #2 (Buy) that has an A for Value and a C for Growth. The company develops medical devices for the treatment of chronic diseases at home.
The consensus price target hints at a 45.9% upside potential for Tactile Systems Technology (TCMD). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
Tactile Systems Technology (TCMD) came out with quarterly earnings of $0.24 per share, beating the Zacks Consensus Estimate of $0.18 per share. This compares to earnings of $0.85 per share a year ago.
MINNEAPOLIS, Oct. 21, 2024 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. (“Tactile Medical”; the “Company”) (Nasdaq: TCMD), a medical technology company providing therapies for people with chronic disorders, today announced that third quarter of fiscal year 2024 financial results will be released after the market closes on Monday, November 4, 2024.
TCMD announces a new study evaluating Flexitouch. The study reveals significant improvements in health-related quality of life and clinical outcomes.
Largest U.S. Prospective Clinical Trial Ever Conducted Demonstrated High Compliance with the Flexitouch® System and Significant Improvements Across Study Endpoints Largest U.S. Prospective Clinical Trial Ever Conducted Demonstrated High Compliance with the Flexitouch® System and Significant Improvements Across Study Endpoints
The average of price targets set by Wall Street analysts indicates a potential upside of 57.3% in Tactile Systems Technology (TCMD). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
FAQ
- What is the primary business of Tactile Systems Technology?
- What is the ticker symbol for Tactile Systems Technology?
- Does Tactile Systems Technology pay dividends?
- What sector is Tactile Systems Technology in?
- What industry is Tactile Systems Technology in?
- What country is Tactile Systems Technology based in?
- When did Tactile Systems Technology go public?
- Is Tactile Systems Technology in the S&P 500?
- Is Tactile Systems Technology in the NASDAQ 100?
- Is Tactile Systems Technology in the Dow Jones?
- When was Tactile Systems Technology's last earnings report?
- When does Tactile Systems Technology report earnings?
- Should I buy Tactile Systems Technology stock now?